COLLEGE STATION, Texas (AP) — Wade Taylor IV had 15 points and a career-high 10 assists, and Zhuric Phelps had 12 points and 10 rebounds in No. 13 Texas A&M's 92-54 win over Abilene Christian on Saturday. Taylor's 15 points passed Vernon Smith, who scored 1,778 points at A&M from 1977-81, for second on Texas A&M's all-time scoring list. Taylor now has 1,779 career points and needs 212 more to pass Bernard King, who scored 1,990 points from 1999-2003, as Texas A&M’s all-time scoring leader. Taylor returned to action after he missed his first career game on Dec. 20 against Houston Christian. The Aggies (11-2) opened the game on a 7-0 run and never looked back. Texas A&M led 48-29 at halftime and ended the game on a 12-0 run over the final 5:24. Quion Williams led Abilene Christian (8-6) with 14 points. Abilene Christian: The Wildcats lost to Texas A&M 81-80 in November 2021 but were too overmatched this season to have a chance at an upset bid. Texas A&M: The Aggies closed nonconference play on a seven-game winning streak in Taylor’s return. The Aggies used a 14-0 run in the first half to build an 18-point lead. Texas A&M guard CJ Wilcher made three straight 3-pointers during the run, including back-to-back from the right wing during fastbreaks. The Wildcats never got within single digits again. Texas A&M continued to show its depth as the Aggies had 45 bench points. Wilcher led the way with a season-high 14 points and forward Andersson Garcia had 12. Twelve players saw action and all 12 scored. The Aggies start Southeastern Conference play against rival Texas on Jan. 4. Abilene Christian closes nonconference action on Dec. 31 at home against Stephen F. Austin. Get poll alerts and updates on AP Top 25 basketball throughout the season. Sign up here. AP college basketball: https://apnews.com/hub/ap-top-25-college-basketball-poll and https://apnews.com/hub/college-basketball
Brisbane news live: Meta outage affecting Facebook, Instagram and WhatsAppClorox Co. stock rises Wednesday, still underperforms marketTransMedics Group, Inc. ( NASDAQ:TMDX – Get Free Report ) traded down 5% on Friday . The company traded as low as $72.68 and last traded at $75.39. 748,139 shares were traded during mid-day trading, a decline of 24% from the average session volume of 982,771 shares. The stock had previously closed at $79.34. Analyst Upgrades and Downgrades A number of analysts recently commented on the company. Needham & Company LLC reaffirmed a “hold” rating and set a $109.00 price objective on shares of TransMedics Group in a research note on Friday. Canaccord Genuity Group decreased their price target on shares of TransMedics Group from $109.00 to $104.00 and set a “buy” rating on the stock in a research note on Wednesday. Oppenheimer cut their price objective on shares of TransMedics Group from $200.00 to $125.00 and set an “outperform” rating for the company in a research report on Tuesday, October 29th. Stephens raised their target price on shares of TransMedics Group from $151.00 to $178.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Finally, Robert W. Baird lowered their target price on shares of TransMedics Group from $200.00 to $150.00 and set an “outperform” rating for the company in a research note on Tuesday, October 29th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $131.80. Check Out Our Latest Stock Analysis on TMDX TransMedics Group Stock Performance TransMedics Group ( NASDAQ:TMDX – Get Free Report ) last issued its earnings results on Monday, October 28th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.17). TransMedics Group had a return on equity of 18.74% and a net margin of 8.14%. The firm had revenue of $108.76 million during the quarter, compared to analysts’ expectations of $115.00 million. During the same period last year, the business posted ($0.12) earnings per share. The company’s quarterly revenue was up 63.7% compared to the same quarter last year. Equities research analysts anticipate that TransMedics Group, Inc. will post 1 EPS for the current year. Insider Activity In related news, insider Tamer I. Khayal sold 2,958 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $148.24, for a total value of $438,493.92. Following the completion of the sale, the insider now directly owns 20,843 shares in the company, valued at approximately $3,089,766.32. This represents a 12.43 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . Also, insider Nicholas Corcoran sold 10,000 shares of the business’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $176.02, for a total value of $1,760,200.00. Following the transaction, the insider now owns 21,105 shares in the company, valued at approximately $3,714,902.10. This represents a 32.15 % decrease in their position. The disclosure for this sale can be found here . Insiders have sold 36,958 shares of company stock valued at $5,230,528 in the last three months. Corporate insiders own 7.00% of the company’s stock. Institutional Investors Weigh In On TransMedics Group Hedge funds have recently modified their holdings of the stock. Vaughan Nelson Investment Management L.P. purchased a new position in TransMedics Group in the 2nd quarter worth approximately $39,862,000. Driehaus Capital Management LLC raised its stake in shares of TransMedics Group by 15.8% during the second quarter. Driehaus Capital Management LLC now owns 1,486,073 shares of the company’s stock valued at $223,832,000 after purchasing an additional 202,867 shares during the period. Principal Financial Group Inc. lifted its position in shares of TransMedics Group by 260.1% during the third quarter. Principal Financial Group Inc. now owns 202,287 shares of the company’s stock worth $31,759,000 after purchasing an additional 146,115 shares in the last quarter. Hood River Capital Management LLC purchased a new position in shares of TransMedics Group in the second quarter valued at $18,854,000. Finally, Canada Pension Plan Investment Board acquired a new stake in TransMedics Group during the 2nd quarter valued at $16,086,000. 99.67% of the stock is currently owned by hedge funds and other institutional investors. TransMedics Group Company Profile ( Get Free Report ) TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Featured Articles Receive News & Ratings for TransMedics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransMedics Group and related companies with MarketBeat.com's FREE daily email newsletter .
The Bard has spoken. With the release of “ A Complete Unknown ” — the movie based on Bob Dylan ’s rise to fame as a young singer — now weeks away, he shared a message about the film, starring Oscar nominee Timothée Chalamet . Dylan, 83, has become a more regular user of X, formerly Twitter, just as many have left the social network for other online spaces. So it’s no surprise that’s where he addressed the coming film Wednesday afternoon. “There’s a movie about me opening soon called A Complete Unknown (what a title!),” Dylan said. “Timothee Chalamet is starring in the lead role. Timmy’s a brilliant actor so I’m sure he’s going to be completely believable as me. Or a younger me. Or some other me.” Chalamet, 28, filmed “A Complete Unknown” in New Jersey and New York this year with director James Mangold (”Walk the Line,” “Girl, Interrupted,” “Cop Land,” “Ford v Ferrari”). READ MORE: See Timothée Chalamet filming Bob Dylan movie in Hoboken as Chalamaniacs buzz around set Jersey spots in the movie, many of them standing in for 1960s Manhattan, include Hoboken , Jersey City , Kearny, Newark , Paterson , Plainfield, Elizabeth, Belleville, West Orange, Kinnelon, Blairstown, Skillman, Highlands, Mountainside , Clifton, Alpine, Red Bank and Cape May (subbing in for Newport, Rhode Island). They were still filming as of June , so the movie, distributed by Searchlight Pictures, was turned around quickly, in time for consideration at the 2025 Oscars. The first trailer for the film was released in July. Chalamet sings Dylan’s songs in the film, including “ Blowin’ in the Wind ” (1963), “ A Hard Rain’s a-Gonna Fall ” (1963) and “ Like A Rolling Stone ” (1965). The movie centers on the beginning of young Dylan’s journey as a folk music enthusiast and artist on the rise and culminates in his controversial decision to “go electric” at the 1965 Newport Folk Festival , where he first publicly performed “Like a Rolling Stone.” There’s a movie about me opening soon called A Complete Unknown (what a title!). Timothee Chalamet is starring in the lead role. Timmy’s a brilliant actor so I’m sure he’s going to be completely believable as me. Or a younger me. Or some other me. The film’s taken from Elijah... The 19-year-old Minnesota native arrives in New York City in 1961, propelled by his love for his folk hero, Woody Guthrie , who had Huntington’s disease and died in 1967. He visits the ailing singer-songwriter, played by Scoot McNairy , at Greystone Park Psychiatric Hospital in Morris Plains, and meets fellow folk star Pete Seeger , played by Edward Norton . Seeger takes Dylan under his wing as the young talent goes from budding performer to standout voice and great hope for spreading the gospel of folk. “The film’s taken from Elijah Wald’s Dylan Goes Electric – a book that came out in 2015,” Dylan continued in his post. “It’s a fantastic retelling of events from the early ‘60s that led up to the fiasco at Newport. After you’ve seen the movie read the book.” MORE: See Timothée Chalamet as Bob Dylan in first trailer for ‘A Complete Unknown,’ filmed in N.J. Mangold’s script, written with Jay Cocks (”Gangsters of New York”), is based on the book, full title “ Dylan Goes Electric! Newport, Seeger, Dylan, and the Night that Split the Sixties .” The movie’s title comes from the lyrics of “ Like a Rolling Stone .” “How does it feel?” Dylan sings. “To be on your own, with no direction home / A complete unknown, like a rolling stone.” Director James Mangold and Timothée Chalamet on the set of "A Complete Unknown." The movie filmed extensively in New Jersey. Macall Polay | Searchlight Pictures Emmy nominee Elle Fanning co-stars as Sylvie Russo , a character based on artist Suze Rotolo , who was in a relationship with Dylan at the start of his career and appears with him on the cover of his 1963 album “ The Freewheelin’ Bob Dylan .” Monica Barbaro (”Top Gun”) plays folk star Joan Baez , who had a relationship with Dylan on and offstage. Barbaro also sings in the movie. Boyd Holbrook (”The Bikeriders”) plays Johnny Cash . Dylan, a Cash fan, became a friend of the Man in Black, and their dynamic is depicted in the film. Mangold, of course, told the story of Cash and his wife, June Carter, in “ Walk the Line ” (2005), starring Joaquin Phoenix and Reese Witherspoon , who won an Oscar for playing June. “ A Complete Unknown ” is in theaters Dec. 25. Stories by Amy Kuperinsky ‘Ocean’s Eleven’ tough guy, professional wrestler dead at 65. ‘A gentle soul,’ George Clooney says. Watch ‘The Voice’ N.J. semifinalist Jan Dan try to defy ‘Gravity’ with ‘instant save’ English band robbed at gunpoint ‘10 minutes’ into U.S. tour (video) Thank you for reading. Please consider supporting NJ.com with a subscription. Amy Kuperinsky may be reached at akuperinsky@njadvancemedia.com and followed at @AmyKup .Japan wary South Korea turmoil may hurt improving bilateral ties